Part 2 Pharmaceutical Lists and Applications for Admission to a Pharmaceutical List

1. 4Preparation of lists
2. 5Applications for inclusion in or amendment to a pharmaceutical list
3. 6Applications involving a minor relocation within a Primary Care Trust’s area
4. 7Applications involving a minor relocation between neighbouring Primary Care Trusts
5. 8Applications involving a change of ownership
6. 9Applications following suspension from the list
7. 10Right of return to pharmaceutical lists
8. 11Refusal: general provisions
9. 12Necessary or desirable test
10. 13Exemption from the necessary or desirable test
11. 14Variation of directed services in respect of exempted premises
12. 15Approved retail areas
13. 16New one-stop primary care centres
14. 17Refusal: distance selling premises
15. 18Refusal: premises which are in a controlled locality but not in a reserved location
16. 19Refusal: fitness to practise grounds
17. 20Imposition of conditions
18. 21Conditional inclusion relating to fitness to practise matters
19. 22Relevant procedures for applications
20. 23Notification of applications
21. 24Determination of applications
22. 25Deferral of consideration of certain applications
23. 26Deferral of consideration of applications on fitness to practise grounds
24. 27Notification of decision
25. 28Notifications by Primary Care Trusts to other persons
26. 29Appeals
27. 30Appeals against imposition of conditions and related decisions
28. 31Determination that an area is a controlled locality
29. 32Appeals relating to rurality of an area
30. 33Notification of an application in respect of premises in a controlled locality
31. 34Decision not to consider an application in respect of premises in a controlled locality
32. 35Pharmaceutical services in reserved locations
33. 36Determination of applications in respect of controlled localities
34. 37Notification of decision in respect of applications in controlled localities
35. 38Appeals in connection with determinations in respect of controlled localities etc
36. 39Procedure after grant of application
37. 40Preliminary consent to be included in a pharmaceutical list
38. 41Effect of preliminary consent